| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/15/2002 | US6338947 Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith |
| 01/15/2002 | US6338946 Determining an immunosuppressant with calcineurin-inhibiting activity by forming a complex with cyclosporin a, calmodulin, calcineurin, calcium ions and detecting calcineurin with an enzyme immunoassy |
| 01/15/2002 | US6338945 Method for identifying cytotoxic T-cell epitopes |
| 01/15/2002 | US6338852 Compounds and methods for diagnosis of tuberculosis |
| 01/15/2002 | US6338821 Method and device for measuring blood coagulation or lysis by viscosity changes |
| 01/15/2002 | US6338820 Apparatus for performing assays at reaction sites |
| 01/15/2002 | US6338790 Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
| 01/15/2002 | US6338720 Collection device for collecting liquid sample |
| 01/15/2002 | US6338282 Portable liquid sampling system |
| 01/15/2002 | US6338276 Multiphase flow metering method and device |
| 01/15/2002 | CA2133560C Hair analysis method |
| 01/15/2002 | CA2121604C Diagnosis and treatment of bacterial dysentery |
| 01/15/2002 | CA2087037C Apparatus and methods for magnetic separation |
| 01/15/2002 | CA2054435C Method of determining the content of hydrogen peroxide in an aqueous solution |
| 01/14/2002 | CA2352399A1 Crystal structure of the 30s ribosome and its use |
| 01/14/2002 | CA2352036A1 Crystal structure of antibiotics bound to the 30s ribosome and its use |
| 01/13/2002 | CA2352930A1 Sample assaying apparatus |
| 01/13/2002 | CA2312051A1 Methylated nucleotide regulation of gene expression |
| 01/10/2002 | WO2002003305A2 Method and apparatus for sequence analysis |
| 01/10/2002 | WO2002003075A2 Methods for detecting activity of clotting factors |
| 01/10/2002 | WO2002003074A1 Diagnostic method for alzheimer's disease based on holo-transcobalamin ii |
| 01/10/2002 | WO2002003073A1 Differential diagnosis of neurological diseases |
| 01/10/2002 | WO2002003072A2 A method for extracting quantitative information relating to interactions between cellular components |
| 01/10/2002 | WO2002003071A2 Modulators of trk protein activity, compositions and uses |
| 01/10/2002 | WO2002003070A1 Method for screening mch receptor antagonist/agonist |
| 01/10/2002 | WO2002003069A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME |
| 01/10/2002 | WO2002003068A1 Insoluble carrier particle nephelometric immunoassay reagent |
| 01/10/2002 | WO2002003067A1 Methods for encoding combinatorial libraries |
| 01/10/2002 | WO2002003066A2 Quantitative fluorescent assay for determining the activity of transport proteins |
| 01/10/2002 | WO2002003065A1 Methods for monitoring treatment of helicobacter infection and for predicting the likelihood of successful eradication |
| 01/10/2002 | WO2002003064A1 Methods for characterizing the viral infectivity status of a host |
| 01/10/2002 | WO2002003063A1 Use of disease-associated gene |
| 01/10/2002 | WO2002003062A2 Whole blood assay method |
| 01/10/2002 | WO2002003060A2 Process for the measurement of dinophysistoxin and of yessotoxin |
| 01/10/2002 | WO2002003059A1 Testing of leather |
| 01/10/2002 | WO2002003058A2 Device and method for making electrical contact with biological cells suspended in a fluid |
| 01/10/2002 | WO2002003057A1 Sensor for helium or hydrogen |
| 01/10/2002 | WO2002003056A1 Method for the analysis of a selected multicomponent sample |
| 01/10/2002 | WO2002003051A1 Flow cell assemblies and methods of spatially directed interaction between liquids and solid surfaces |
| 01/10/2002 | WO2002003047A2 Method and apparatus for the detection of volatile products in a sample |
| 01/10/2002 | WO2002002823A2 Polynucleotide sequence assay |
| 01/10/2002 | WO2002002819A1 Method of screening for chemotherapeutic treatments for cancer |
| 01/10/2002 | WO2002002816A2 Methods for identifying mitochondrial divalent cation transporters |
| 01/10/2002 | WO2002002811A2 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 01/10/2002 | WO2002002810A2 Method for qualitative and/or quantitative detecting of molecular interactions on probe arrays |
| 01/10/2002 | WO2002002809A2 Diagnosis of behavioural disorders, neurological disorders and cancer |
| 01/10/2002 | WO2002002808A2 Method and nucleic acids for the analysis of astrocytomas |
| 01/10/2002 | WO2002002807A2 Diagnosis of diseases associated with cell signalling |
| 01/10/2002 | WO2002002806A2 Method and nucleic acids for analysing the methylation of genes implicated in pharmacogenomics |
| 01/10/2002 | WO2002002802A1 Method of measuring total homocysteine |
| 01/10/2002 | WO2002002801A1 Method of assaying the function of fc fragment of antibody |
| 01/10/2002 | WO2002002799A1 Characterizing a brain tumor |
| 01/10/2002 | WO2002002798A2 Methods and compositions for the modulation of chorismate synthase and chorismate mutase expression or activity in plants |
| 01/10/2002 | WO2002002797A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 01/10/2002 | WO2002002794A2 Integrated microarray devices |
| 01/10/2002 | WO2002002792A1 Signal amplification with lollipop probes |
| 01/10/2002 | WO2002002784A1 Regulated gene expression in yeast and methods of use |
| 01/10/2002 | WO2002002780A2 Human serine-threonine kinase |
| 01/10/2002 | WO2002002774A2 32626, a human udp-glycosyltransferase and uses thereof |
| 01/10/2002 | WO2002002773A2 Dual specificity antibodies and methods of making and using |
| 01/10/2002 | WO2002002772A2 Human extracellular matrix (ecm)-related tumor marker |
| 01/10/2002 | WO2002002769A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 01/10/2002 | WO2002002764A2 High molecular weight derivatives of vitamin k-dependent polypeptides |
| 01/10/2002 | WO2002002757A2 Adenylyl and guanylyl cyclases |
| 01/10/2002 | WO2002002756A2 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 01/10/2002 | WO2002002752A1 Attenuated bovine respiratory syncytial virus |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002740A2 Methods and compositions for determining gene function |
| 01/10/2002 | WO2002002647A1 Improved microgels and films |
| 01/10/2002 | WO2002002641A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | WO2002002638A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/10/2002 | WO2002002635A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002631A1 Structure-based drug design method to identify compounds that bind to cd81, a cell receptor for hepatitis-c |
| 01/10/2002 | WO2002002627A2 Interferon-like protein zcyto21 |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002624A2 B7-like molecules and uses thereof |
| 01/10/2002 | WO2002002623A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | WO2002002610A2 Secretion and trafficking molecules |
| 01/10/2002 | WO2002002609A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002594A1 Peptide for swine pregnancy test reagents and swine pregnancy test reagents |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002586A1 Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same |
| 01/10/2002 | WO2002002585A2 Low fluorescence nylon/glass composites for microdiagnostics |
| 01/10/2002 | WO2002002584A1 Base analogues |
| 01/10/2002 | WO2002002557A2 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands |
| 01/10/2002 | WO2002002488A2 Methods and compounds for modulating nuclear receptor coactivator binding |
| 01/10/2002 | WO2002002465A1 Device for determining the calcite equilibrium in water |
| 01/10/2002 | WO2002002236A1 Internal adapter with a pellet well for a centrifuge container |
| 01/10/2002 | WO2002002226A2 Support plate and method for the carrying out of functional tests |
| 01/10/2002 | WO2002002150A2 Stable radioiodine conjugates and methods for their synthesis |
| 01/10/2002 | WO2002002147A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | WO2002002131A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | WO2002002055A2 Antifungal compounds and methods of use |
| 01/10/2002 | WO2002002054A2 Methods and compositions for the diagnosis of schizophrenia |
| 01/10/2002 | WO2002002049A1 Apparatus for mixing a fluid medium |
| 01/10/2002 | WO2002002009A1 Apparatus and method for screening, olfactory mucosa stimulating compound found by the screening method, and therapeutic apparatus and electrode section for measurement |